Robuta

https://www.wallstreetzen.com/stocks/us/nasdaq/atra/ownership Atara Biotherapeutics Stock Ownership - Who Owns Atara Biotherapeutics in 2026? | WallStreetZen atara biotherapeuticsstock ownershipwho owns https://www.hl.co.uk/shares/shares-search-results/a/atara-biotherapeutics-inc-usd1.0001 Atara Biotherapeutics Inc USD0.0001 share price | ATRA The latest Atara Biotherapeutics Inc USD0.0001 share price (ATRA). View recent trades and share price information for Atara Biotherapeutics Inc USD0.0001. atara biotherapeuticsshare priceincatra https://investingnews.com/tag/atara-biotherapeutics atara biotherapeutics | INN atara biotherapeuticsinn https://layoffalert.org/company/atara-biotherapeutics Atara Biotherapeutics Layoffs: WARN Act Notices & History | LayoffAlert.org | LayoffAlert.org Track 4 WARN Act layoff notices for Atara Biotherapeutics. 88 employees affected across 1 state. Complete layoff history with dates, locations, and employee... atara biotherapeuticswarn actlayoffsnoticeshistory https://www.macrotrends.net/stocks/charts/ATRA/atara-biotherapeutics/current-ratio Atara Biotherapeutics Current Ratio 2013-2025 | ATRA | MacroTrends Atara Biotherapeutics current ratio from 2013 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term... atara biotherapeuticscurrent ratioatramacrotrends https://investors.atarabio.com/news-events/press-releases?page=16 Press Releases :: Atara Biotherapeutics (ATRA) press releasesatara biotherapeuticsatra https://fitzsimonsinnovation.com/news/atara-therapeutics-named-one-of-biospaces-top-neurodegenerative-readouts-of-2023/ Atara Biotherapeutics Named one of BioSpace's top Neurodegenerative Readouts of 2023 - News -... atara biotherapeuticsone of https://investors.atarabio.com/sec-filings/section-16-filings?page=63 Section 16 Filings :: Atara Biotherapeutics (ATRA) atara biotherapeuticssectionfilingsatra https://www.biospace.com/atara-biotherapeutics-exclusively-licenses-mesothelin-targeted-car-t-immunotherapy-for-solid-tumorsatara-biotherapeutics-exclusively-licenses-mesothelin-targeted-car-t-immunotherapy-for-solid-tumors Atara Biotherapeutics Exclusively Licenses Mesothelin-Targeted CAR T Immunotherapy for Solid... Jan 7, 2019 - Initial results from ongoing Phase 1 study for mesothelin-targeted CAR T support activity and safety in patients with advanced solid tumors atara biotherapeuticsexclusivelylicensesmesothelin https://www.portofspainpoliticalmonitor.com/article/910526489-atra-investors-have-opportunity-to-lead-atara-biotherapeutics-inc-securities-fraud-lawsuit-with-the-schall-law-firm ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with... https://www.newyorkdailyledger.com/article/910636835-bragar-eagel-squire-p-c-reminds-atara-biotherapeutics-inc-investors-they-have-until-may-22nd-to-seek-lead-plaintiff-role-in-class-action-lawsuit Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd... New York Daily Ledger is an online news publication focusing on the New York: The latest news from New York https://www.newhampshirepoliticalreporter.com/article/910624353-rosen-a-longstanding-law-firm-encourages-atara-biotherapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class ROSEN, A LONGSTANDING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel... https://ammanpoliticalpress.com/article/910636835-bragar-eagel-squire-p-c-reminds-atara-biotherapeutics-inc-investors-they-have-until-may-22nd-to-seek-lead-plaintiff-role-in-class-action-lawsuit Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd... https://texaspoliticalbrief.com/article/910624353-rosen-a-longstanding-law-firm-encourages-atara-biotherapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class ROSEN, A LONGSTANDING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel... https://www.consumerproductsafrica.com/article/910526489-atra-investors-have-opportunity-to-lead-atara-biotherapeutics-inc-securities-fraud-lawsuit-with-the-schall-law-firm ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with... Consumer Products Africa is an online news publication focusing on consumer goods in the Africa: Informing on consumer products news in Africa https://www.maldivespoliticaldaily.com/article/910636835-bragar-eagel-squire-p-c-reminds-atara-biotherapeutics-inc-investors-they-have-until-may-22nd-to-seek-lead-plaintiff-role-in-class-action-lawsuit Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd... https://www.businesswire.com/news/home/20201102005009/en/Atara-Biotherapeutics-to-Announce-Third-Quarter-2020-Financial-Results-on-Monday-November-9-2020 Atara Biotherapeutics to Announce Third Quarter 2020 Financial Results on Monday, November 9, 2020 Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative ... https://www.northdakotapoliticaljournal.com/article/910624353-rosen-a-longstanding-law-firm-encourages-atara-biotherapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class ROSEN, A LONGSTANDING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel... https://www.virginiapoliticalwire.com/article/910612161-pomerantz-law-firm-announces-the-filing-of-a-class-action-against-atara-biotherapeutics-inc-and-certain-officers-atra Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and... https://www.ohiopoliticstoday.com/article/910636835-bragar-eagel-squire-p-c-reminds-atara-biotherapeutics-inc-investors-they-have-until-may-22nd-to-seek-lead-plaintiff-role-in-class-action-lawsuit Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd... https://www.nebraskapoliticstoday.com/article/910612161-pomerantz-law-firm-announces-the-filing-of-a-class-action-against-atara-biotherapeutics-inc-and-certain-officers-atra Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and... https://www.kingstonpoliticalupdate.com/article/910612161-pomerantz-law-firm-announces-the-filing-of-a-class-action-against-atara-biotherapeutics-inc-and-certain-officers-atra Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and... https://www.tongapoliticsbulletin.com/article/910624353-rosen-a-longstanding-law-firm-encourages-atara-biotherapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class ROSEN, A LONGSTANDING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel... https://www.ohiopoliticstoday.com/article/910612161-pomerantz-law-firm-announces-the-filing-of-a-class-action-against-atara-biotherapeutics-inc-and-certain-officers-atra Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and... https://www.michiganpoliticalreporter.com/article/910624353-rosen-a-longstanding-law-firm-encourages-atara-biotherapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class ROSEN, A LONGSTANDING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel... https://www.californiapoliticstoday.com/article/910636835-bragar-eagel-squire-p-c-reminds-atara-biotherapeutics-inc-investors-they-have-until-may-22nd-to-seek-lead-plaintiff-role-in-class-action-lawsuit Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd... https://www.castriespoliticaljournal.com/article/910636835-bragar-eagel-squire-p-c-reminds-atara-biotherapeutics-inc-investors-they-have-until-may-22nd-to-seek-lead-plaintiff-role-in-class-action-lawsuit Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd... https://www.ashgabatpoliticalobserver.com/article/910624353-rosen-a-longstanding-law-firm-encourages-atara-biotherapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class ROSEN, A LONGSTANDING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel... https://www.pennsylvaniapoliticsjournal.com/article/910636835-bragar-eagel-squire-p-c-reminds-atara-biotherapeutics-inc-investors-they-have-until-may-22nd-to-seek-lead-plaintiff-role-in-class-action-lawsuit Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd... https://groowe.com/newsroom/zB9qQsGGzn ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics,... https://indianapoliticalwire.com/article/910636835-bragar-eagel-squire-p-c-reminds-atara-biotherapeutics-inc-investors-they-have-until-may-22nd-to-seek-lead-plaintiff-role-in-class-action-lawsuit Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd... https://politicaljournalofmontana.com/article/910636835-bragar-eagel-squire-p-c-reminds-atara-biotherapeutics-inc-investors-they-have-until-may-22nd-to-seek-lead-plaintiff-role-in-class-action-lawsuit Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd... https://www.indianapoliticalwire.com/article/910624353-rosen-a-longstanding-law-firm-encourages-atara-biotherapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class ROSEN, A LONGSTANDING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel... https://oregonpoliticaljournal.com/article/910612161-pomerantz-law-firm-announces-the-filing-of-a-class-action-against-atara-biotherapeutics-inc-and-certain-officers-atra Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and... https://fintechworldpost.com/article/911143365-bronstein-gewirtz-grossman-llc-urges-atara-biotherapeutics-inc-investors-to-act-class-action-filed-alleging-investor-harm Bronstein, Gewirtz & Grossman LLC Urges Atara Biotherapeutics, Inc. Investors to Act: Class Action... https://www.dushanbepoliticswire.com/article/910636835-bragar-eagel-squire-p-c-reminds-atara-biotherapeutics-inc-investors-they-have-until-may-22nd-to-seek-lead-plaintiff-role-in-class-action-lawsuit Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd...